Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF and Vaccine Sites in Melanoma Peptides Immunization
NCT00089193Phase 2Completed
- Start
- Sep 2003
- Primary completion
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in melanoma. Started Sep 2003; status: completed.
02
Drugs
sargramostim
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00089193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089193.